Dubé MP - Search Results

1

Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.

Dubé MP, Wu JW, Aberg JA, Deeg MA, Alston-Smith BL, McGovern ME, Lee D, Shriver SL, Martinez AI, Greenwald M, Stein JH; AIDS Clinical Trials Group A5148 Study Team. Dubé MP, et al. Antivir Ther. 2006;11(8):1081-9. Antivir Ther. 2006. PMID: 17302378 Free PMC article. Clinical Trial.

2

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.

Dubé MP, Sprecher D, Henry WK, Aberg JA, Torriani FJ, Hodis HN, Schouten J, Levin J, Myers G, Zackin R, Nevin T, Currier JS; Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Dubé MP, et al. Clin Infect Dis. 2000 Nov;31(5):1216-24. doi: 10.1086/317429. Epub 2000 Nov 7. Clin Infect Dis. 2000. PMID: 11073755

3

Disorders of glucose metabolism in patients infected with human immunodeficiency virus.

Dubé MP. Dubé MP. Clin Infect Dis. 2000 Dec;31(6):1467-75. doi: 10.1086/317491. Epub 2000 Nov 29. Clin Infect Dis. 2000. PMID: 11096014 Review.

4

Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients.

Dubé MP, Edmondson-Melançon H, Qian D, Aqeel R, Johnson D, Buchanan TA. Dubé MP, et al. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):130-4. doi: 10.1097/00126334-200106010-00006. J Acquir Immune Defic Syndr. 2001. PMID: 11404534 Clinical Trial.

5

Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy.

Dubé MP, Qian D, Edmondson-Melançon H, Sattler FR, Goodwin D, Martinez C, Williams V, Johnson D, Buchanan TA. Dubé MP, et al. Clin Infect Dis. 2002 Aug 15;35(4):475-81. doi: 10.1086/341489. Epub 2002 Jul 23. Clin Infect Dis. 2002. PMID: 12145733

6

A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team.

Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani FJ, Lennox JL, Dube MP, MacGregor RR, Currier JS; AIDS Clinical Trial Group 393 Study Team. Aberg JA, et al. Among authors: dube mp. J Infect Dis. 2003 Apr 1;187(7):1046-52. doi: 10.1086/368413. Epub 2003 Mar 14. J Infect Dis. 2003. PMID: 12660918 Clinical Trial.

7

Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.

Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ; Adult AIDS Clinical Trials Group Cardiovascular Subcommittee; HIV Medical Association of the Infectious Disease Society of America. Dubé MP, et al. Clin Infect Dis. 2003 Sep 1;37(5):613-27. doi: 10.1086/378131. Epub 2003 Aug 15. Clin Infect Dis. 2003. PMID: 12942391 Review. No abstract available.

8

Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy.

Young EM, Considine RV, Sattler FR, Deeg MA, Buchanan TA, Degawa-Yamauchi M, Shankar S, Edmondson-Melançon H, Hernandez J, Dubé MP. Young EM, et al. Among authors: dube mp. Cardiovasc Toxicol. 2004;4(2):179-86. doi: 10.1385/ct:4:2:179. Cardiovasc Toxicol. 2004. PMID: 15371633 Clinical Trial.

9

The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy.

Dubé MP, Kitch DW, Parker RA, Alston-Smith BL, Mulligan K. Dubé MP, et al. Clin Chem Lab Med. 2005;43(9):947-52. doi: 10.1515/CCLM.2005.162. Clin Chem Lab Med. 2005. PMID: 16176175

10

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.

Dubé MP, Parker RA, Tebas P, Grinspoon SK, Zackin RA, Robbins GK, Roubenoff R, Shafer RW, Wininger DA, Meyer WA 3rd, Snyder SW, Mulligan K. Dubé MP, et al. AIDS. 2005 Nov 4;19(16):1807-18. doi: 10.1097/01.aids.0000183629.20041.bb. AIDS. 2005. PMID: 16227788 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters